In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 14, 2014, Pages 5248-5253

  Halliday, John ^a,b   Helmy, Karim ^a,c,d,e   Pattwell, Siobhan S ^f   Pitter, Kenneth L ^a   LaPlant, Quincey ^a   Ozawa, Tatsuya ^f,g   Holland, Eric C ^f,g  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Gerstner Sloan Kettering Graduate School of Biomedical Sciences   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d University of Medicine and Dentistry of New Jersey   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f USA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53; TEMSIROLIMUS; TRANSCRIPTION FACTOR E2F;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIOMA CELL; IN VIVO STUDY; IONIZING RADIATION; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; TRANSGENIC MOUSE; TRANSLATING RIBOSOME AFFINITY PURIFICATION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN NEOPLASMS; E2F TRANSCRIPTION FACTORS; GLIOBLASTOMA; MESODERM; MICE; MICE, TRANSGENIC; NEURONS; RADIATION TOLERANCE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84898022873     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1321014111     Document Type: Article

References (32)

1. Huse JT, Holland EC (2010) Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10(5):319-331.
2. Lee SW, et al. (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43(1):79-88.
3. Chan JL, et al. (2002) Survival and failure patterns of high-grade gliomas after threedimensional conformal radiotherapy. J Clin Oncol 20(6):1635-1642.
4. Davis LW (1989) Malignant glioma-a nemesis which requires clinical and basic investigation in radiation oncology. Int J Radiat Oncol Biol Phys 16(6):1355-1365.
5. Amberger-Murphy V (2009) Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9(3):381-390.
6. Barcellos-Hoff MH, Newcomb EW, Zagzag D, Narayana A (2009) Therapeutic targets in malignant glioblastoma microenvironment. Semin Radiat Oncol 19(3):163-170.
7. Charles N, et al. (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6(2):141-152.
8. Bao S, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760.
9. Hambardzumyan D, et al. (2008) PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 22(4):436-448.
10. Jamal M, Rath BH, Williams ES, Camphausen K, Tofilon PJ (2010) Microenvironmental regulation of glioblastoma radioresponse. Clin Cancer Res 16(24):6049-6059.
11. Helmy K, et al. (2012) Identification of global alteration of translational regulation in glioma in vivo. PLoS ONE 7(10):e46965.
12. Phillips HS, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173.
13. Verhaak RG, et al.; Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110.
14. Braunstein S, Badura ML, Xi Q, Formenti SC, Schneider RJ (2009) Regulation of protein synthesis by ionizing radiation. Mol Cell Biol 29(21):5645-5656.
15. Powley IR, et al. (2009) Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev 23(10):1207-1220.
16. Lü X, de la Peña L, Barker C, Camphausen K, Tofilon PJ (2006) Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res 66(2):1052-1061.
17. Heiman M, et al. (2008) A translational profiling approach for the molecular characterization of CNS cell types. Cell 135(4):738-748.
18. Shih AH, et al. (2004) Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64(14):4783-4789.
19. Fomchenko EI, et al. (2011) Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. PLoS ONE 6(7): e20605.
20. Dougherty JD, et al. (2012) Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Res 72(18): 4856-4868.
21. Squatrito M, et al. (2010) Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 18(6):619-629.
22. Doyle JP, et al. (2008) Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135(4):749-762.
23. Li XH, Ha CT, Fu D, Xiao M (2012) REDD1 protects osteoblast cells from gamma radiation-induced premature senescence. PLoS ONE 7(5):e36604.
24. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
25. Pitter KL, et al. (2011) Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PLoS ONE 6(1):e14545.
26. Dornan D, et al. (2004) Interferon regulatory factor 1 binding to p300 stimulates DNAdependent acetylation of p53. Mol Cell Biol 24(22):10083-10098.
27. Cerami E, et al. (2012) The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401-404.
28. Carro MS, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279):318-325.
29. Hu X, et al. (2005) mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7(4):356-368.
30. Hirai H, Karian P, Kikyo N (2011) Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J 438(1):11-23.
31. Demoulin JB, Renauld JC (1998) Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther 4(4):243-256.
32. Bhat KP, et al. (2013) Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 24(3):331-346.